参考文献:
[1]LI C, LI WG, XU XY. Clinical advances in hepatorenal syndrome in liver cirrhosis[J]. J Clin Intern Med, 2019, 36(12): 799-802.(in Chinese)
李晨, 李文刚, 徐小元. 肝硬化肝肾综合征的临床进展[J]. 临床内科病杂志, 2019, 36(12): 799-802.
[2]GINS A, ESCORSELL A, GINS P, et al. Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites[J]. Gastroenterology, 1993, 105(1): 229-236.
[3]WAGN YJ, PING XG. Clinical effect of ascites ultrafiltration and reinfusion in treatment of patients with decompensated cirrhosis, intractable liver ascites, and type Ⅱ hepatorenal syndrome[J].Chin J Ctrl Endem Dis, 2017, 32(10): 249-253.(in Chinese)
王艳景, 平骁功. 腹水超滤浓缩回输治疗肝硬化失代偿期合并顽固性肝腹水伴Ⅱ型肝肾综合征的临床效果[J].中国地方病防治杂志, 2017, 32(10): 249-253.
[4]GINS P, SOL E, ANGELI P, et al. Hepatorenal syndrome[J]. Nat Rev Dis Primers, 2018, 4(1): 23.
[5]de MATTOS Z, de MATTOS AA, MNDEZ-SNCHEZ N. Hepatorenal syndrome: Current concepts related to diagnosis and management[J]. Ann Hepatol, 2016, 15(4): 474-481.
[6]PERICLEOUSM, SARNOWSKIA, MOREA, et al. The clinical management of abdominal ascites, spontaneous bacterial peritonitis and hepatorenalsyndrome: A review of curent guidelines and recommendations[J]. Eur J Gastroenterol Hepatol, 2016, 28(3): e108.
[7]European Association for the Study of the Liver. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis[J]. J Hepatol, 2010, 53(3): 397-417.
[8]WIEST R, KRAG A, GERBES A. Spontaneous bacterial peritonitis: Recent guidelines and beyond[J]. Gut, 2012, 61(2): 297-310.
[9]EGEROD ISRAELSEN M, GLUUD LL, KRAG A. Acute kidney injury and hepatorenal syndrome in cirrhosis[J]. J Gastroenterol Hepato, 2015, 30(2): 236-243.
[10]LI SY, TIAN YJ, LI DC, et al. Risk factors for hepatorenal syndrome in patients with decompensated cirrhosis[J]. J Chin Physician, 2016, 18(11): 1723-1725. (in Chinese)
李思阳, 田英俊, 李德春, 等. 肝硬化患者失代偿期发生肝肾综合征的危险因素分析[J]. 中国医师杂志, 2016, 18(11): 1723-1725.
[11]ZHU XZ, ZHAI YF, WANG JJ. Study on the risk factors of the occurrence of hepato renal syndrome for patients with acute on chronic hepatitis B liver failure[J].J Chin Physician, 2014, 16 (9): 1196-1199. (in Chinese)
朱喜增, 翟玉峰, 王江华. 慢加急性乙型肝炎肝衰竭患者发生肝肾综合征的影响因素研究[J].中国医师杂志, 2014, 16 (9): 1196-1199.
[12]YE YN, ZHANG ZJ, HE G, et al. Analysis of high-risk factors for hepatorenal syndrome in patients with hepatitis B-related acute-on-chronic liver failure[J]. Hainan Med J, 2019, 30(24): 3145-3148. (in Chinese)
叶一农, 张志侨, 何纲, 等. 乙型肝炎相关慢加急性肝衰竭患者发生肝肾综合征的高危因素分析[J]. 海南医学, 2019, 30(24): 3145-3148.
[13]ARROYO V, GINS P, GERBES AL, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club[J]. Hepatology, 1996, 23(1): 164-176.
[14]SALERNO F, GERBES A, GINS P, et al. Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis[J]. Gut, 2007, 56(9): 1310-1318.
[15]ANGELI P, GINS P, WONG F, et al. Diagnosis and management of acute kidney injury in patients with cirrhosis: Revised consensus recommendations of the International Club of Ascites[J]. J Hepatol, 2015, 62(4): 968-974.
[16]Chinese Society of Hepatology, Chinese Medical Association. Guidelines on the management of ascites and complications in cirrhosis[J]. J Clin Hepatol, 2017, 33(10): 1847-1863. (in Chinese)
中华医学会肝病分会. 肝硬化腹水及相关并发症的诊疗指南[J]. 临床肝胆病杂志, 2017, 33(10): 1874-1863.
[17]BELCHER JM, EDELSTEIN CL, PARIKH CR. Clinical applications of biomarkers for acute kidney injury[J]. Am J Kidney Dis, 2011, 57(6): 930-940.
[18]BELCHER JM, SANYAL AJ, PEIXOTO AJ, et al. Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury[J]. Hepatology, 2014, 60(2): 622-632.
[19]HUELIN P, SOL E, ELIA C, et al. Neutrophil gelatinase-associated lipocalin for assessment of acute kidney injury in cirrhosis: A prospective study[J]. Hepatology, 2019, 70(1): 319-333.
[20]AMIN AA, ALABSAWY EI, JALAN R, et al. Epidemiology, pathophysiology, and management of hepatorenal syndrome[J]. Semin Nephrol, 2019, 39(1): 17-30.
[21]European Association for the Study of the Liver. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis[J]. J Hepatol, 2018, 69(2): 406-460.
[22]CHAWLA LS, BELLOMO R, BIHORAC A, et al. Acute kidney disease and renal recovery: Consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup[J]. Nat Rev Nephrol, 2017, 13(4): 241-257.
[23]HUAN HD, CHENG CW. Latest advances in the definition, typing, and pathophysiology of hepatorenal syndrome[J]. Chin Hepatol, 2020, 25(1): 7-9. (in Chinese)
宦红娣, 陈成伟. 肝肾综合征定义、分型及病理生理新进展[J]. 肝脏, 2020, 25(1): 7-9.
[24]ANGELI P, GARCIA-TSAO G, NADIM MK, et al. News in pathophysiology, definition and classification of hepatorenal syndrome: A step beyond the International Club of Ascites (ICA) consensus document[J]. J Hepatol, 2019, 71(4): 811-822.